1. Home
  2. ONMD vs CCEL Comparison

ONMD vs CCEL Comparison

Compare ONMD & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneMedNet Corp

ONMD

OneMedNet Corp

HOLD

Current Price

$0.75

Market Cap

35.9M

Sector

N/A

ML Signal

HOLD

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

HOLD

Current Price

$3.48

Market Cap

30.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONMD
CCEL
Founded
2006
1989
Country
United States
United States
Employees
23
N/A
Industry
Managed Health Care
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.9M
30.9M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
ONMD
CCEL
Price
$0.75
$3.48
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
624.7K
7.7K
Earning Date
05-13-2026
04-14-2026
Dividend Yield
N/A
4.26%
EPS Growth
N/A
N/A
EPS
N/A
0.07
Revenue
N/A
$25,384,279.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$48.86
Revenue Growth
N/A
9.76
52 Week Low
$0.44
$2.72
52 Week High
$4.22
$5.43

Technical Indicators

Market Signals
Indicator
ONMD
CCEL
Relative Strength Index (RSI) 60.57 51.77
Support Level $0.77 $3.00
Resistance Level $0.93 $3.92
Average True Range (ATR) 0.09 0.27
MACD 0.01 0.00
Stochastic Oscillator 84.81 46.93

Price Performance

Historical Comparison
ONMD
CCEL

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Share on Social Networks: